Literature DB >> 9620373

Characteristics of Arthrobacter cumminsii, the most frequently encountered Arthrobacter species in human clinical specimens.

G Funke1, M Pagano-Niederer, B Sjödén, E Falsen.   

Abstract

During a 2-year period, 10 strains of Arthrobacter cumminsii were isolated in or received by a Swiss routine clinical bacteriology laboratory, and 5 further isolates were referred to a Swedish bacteriology reference center over a 5-year period, making A. cumminsii the most frequently encountered Arthrobacter species in these two laboratories. The present report outlines the clinical features of the 15 A. cumminsii strains and presents an extended biochemical characterization of this microorganism. A. cumminsii exhibits a unique cellular fatty acid pattern with the consistent presence of C14:0i and C14:0 fatty acids as well as relatively large amounts of C16:0i and C16:0 fatty acids usually not seen in other Arthrobacter spp. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was found to be a useful tool for confirmation of the identification of A. cumminsii. The MICs of 39 antimicrobial agents were determined, and it was demonstrated that aminoglycosides and quinolones had only weak activities against A. cumminsii strains, in contrast to their activities against most other coryneform bacteria. As a result of the extended characterization of A. cumminsii, an emended description of this species is presented. Due to the lack of A. cumminsii in established identification systems, it is most likely that this species is underdiagnosed in many routine clinical bacteriology laboratories.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620373      PMCID: PMC104873     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Grouping of some clinically relevant gram-positive rods by automated fatty acid analysis. Diagnostic implications.

Authors:  A Von Graevenitz; G Osterhout; J Dick
Journal:  APMIS       Date:  1991-02       Impact factor: 3.205

2.  Septicemia due to Arthrobacter species in a neutropenic patient with acute lymphoblastic leukemia.

Authors:  C L Hsu; L Y Shih; H S Leu; C L Wu; G Funke
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

3.  Endophthalmitis involving an Arthrobacter-like organism following intraocular lens implantation.

Authors:  J Esteban; J Bueno; J J Perez-Santonja; F Soriano
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 4.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

Authors:  G Funke; V Pünter; A von Graevenitz
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  An identification scheme for rapidly and aerobically growing gram-positive rods.

Authors:  A von Graevenitz; G Funke
Journal:  Zentralbl Bakteriol       Date:  1996-07

8.  Differentiation of Brevibacterium spp. encountered in clinical specimens.

Authors:  G Funke; A Carlotti
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Cellular fatty acid composition as an adjunct to the identification of asporogenous, aerobic gram-positive rods.

Authors:  K A Bernard; M Bellefeuille; E P Ewan
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  7 in total

1.  Identification of Arthrobacter oxydans, Arthrobacter luteolus sp. nov., and Arthrobacter albus sp. nov., isolated from human clinical specimens.

Authors:  G Wauters; J Charlier; M Janssens; M Delmée
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans.

Authors:  M Drancourt; P Berger; D Raoult
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Identities of Arthrobacter spp. and Arthrobacter-like bacteria encountered in human clinical specimens.

Authors:  Irene S Mages; Reinhard Frodl; Kathryn A Bernard; Guido Funke
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

4.  Respiratory Microbiome of Endangered Southern Resident Killer Whales and Microbiota of Surrounding Sea Surface Microlayer in the Eastern North Pacific.

Authors:  Stephen A Raverty; Linda D Rhodes; Erin Zabek; Azad Eshghi; Caroline E Cameron; M Bradley Hanson; J Pete Schroeder
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 5.  The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women.

Authors:  Yashini Govender; Iwona Gabriel; Vatche Minassian; Raina Fichorova
Journal:  Front Cell Infect Microbiol       Date:  2019-05-01       Impact factor: 5.293

6.  The female urinary microbiome: a comparison of women with and without urgency urinary incontinence.

Authors:  Meghan M Pearce; Evann E Hilt; Amy B Rosenfeld; Michael J Zilliox; Krystal Thomas-White; Cynthia Fok; Stephanie Kliethermes; Paul C Schreckenberger; Linda Brubaker; Xiaowu Gai; Alan J Wolfe
Journal:  MBio       Date:  2014-07-08       Impact factor: 7.867

7.  Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs.

Authors:  Kyung R Min; Adriana Galvis; Katherine L Baquerizo Nole; Rohita Sinha; Jennifer Clarke; Robert S Kirsner; Dragana Ajdic
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.